Back to ventures
OX

OncoX

2025

Active

Cutting-Edge Therapeutics & Treatments to eventually help solve Cancer

Pharmaceuticals

Total Raised

-

Team

15

Revenue

Pre-Revenue

Exit Value

Overview

We are commercialising groundbreaking achievements being carried out in Cancer Research

The Problem

Cancer

Our Solution

Aggressively get in touch with laboratories worldwide, doing pioneering research in Cancer Therapeutics, offer them our commercialisation Expertise. Scale.

Traction

  • Introducing Novel Lung-Cancer Diagnostics to Indian Market which reduces TAT for Liquid Biopsies from 30 days to 2 days
  • MOU's signed to make the product profitable in Year 1
  • 2 drugs in Pipeline

Looking Ahead

INR 500CR+ Annualised Revenue expected by 2032